EGFR c.103_104delinsGA ;(p.S35D)

Variant ID: 7-55209993-AG-GA

NM_005228.3(EGFR):c.103_104delinsGA;(p.S35D)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Combination treatment including targeted therapy for advanced hepatocellular carcinoma.

Oncotarget
Lin, Jianzhen J; Wu, Liangcai L; Bai, Xue X; Xie, Yuan Y; Wang, Anqiang A; Zhang, Haohai H; Yang, Xiaobo X; Wan, Xueshuai X; Lu, Xin X; Sang, Xinting X; Zhao, Haitao H
Publication Date: 2016-10-25

Variant appearance in text: EGFR: S35D
PubMed Link: 27626176
Variant Present in the following documents:
  • Main text
  • oncotarget-07-71036.pdf
View BVdb publication page



BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.

Cancer Cell
Lang, Jing-Yu JY; Hsu, Jennifer L JL; Meric-Bernstam, Funda F; Chang, Chun-Ju CJ; Wang, Qingfei Q; Bao, Yi Y; Yamaguchi, Hirohito H; Xie, Xiaoming X; Woodward, Wendy A WA; Yu, Dihua D; Hortobagyi, Gabriel N GN; Hung, Mien-Chie MC
Publication Date: 2011-09-13

Variant appearance in text: EGFR: S35D
PubMed Link: 21907925
Variant Present in the following documents:
  • Main text
View BVdb publication page